General Insurance Corporation of India (NSE: GICRE)
India
· Delayed Price · Currency is INR
366.50
-4.80 (-1.29%)
Nov 21, 2024, 3:30 PM IST
GICRE Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
Premiums & Annuity Revenue | 339,853 | 336,454 | 359,821 | 395,438 | 399,494 | 443,316 | Upgrade
|
Total Interest & Dividend Income | 79,594 | 75,388 | 62,366 | 50,615 | 46,560 | 41,480 | Upgrade
|
Gain (Loss) on Sale of Investments | 40,141 | 39,935 | 43,694 | 43,859 | 40,975 | 27,418 | Upgrade
|
Total Revenue | 459,587 | 451,777 | 465,880 | 489,912 | 487,029 | 512,214 | Upgrade
|
Revenue Growth (YoY) | -0.13% | -3.03% | -4.91% | 0.59% | -4.92% | 15.10% | Upgrade
|
Policy Benefits | 310,523 | 316,178 | 332,042 | 367,035 | 369,289 | 431,504 | Upgrade
|
Policy Acquisition & Underwriting Costs | 64,989 | 63,012 | 56,507 | 70,261 | 80,247 | 75,619 | Upgrade
|
Selling, General & Administrative | 4,869 | 4,198 | 3,683 | 3,714 | 3,015 | 4,456 | Upgrade
|
Provision for Bad Debts | 43.2 | -78.8 | 3,295 | 2,632 | -3,683 | 1,317 | Upgrade
|
Other Operating Expenses | 30.5 | - | - | - | - | - | Upgrade
|
Total Operating Expenses | 370,218 | 373,213 | 394,077 | 457,287 | 452,358 | 521,597 | Upgrade
|
Operating Income | 89,369 | 78,564 | 71,803 | 32,625 | 34,671 | -9,383 | Upgrade
|
Interest Expense | -838.09 | -838.09 | -807.5 | -627.48 | -608.74 | -275.08 | Upgrade
|
Earnings From Equity Investments | 3,426 | 1,777 | 3,302 | 1,875 | 1,666 | 918.39 | Upgrade
|
Currency Exchange Gain (Loss) | -421.51 | 1,436 | 9,228 | 5,346 | -3,483 | 5,794 | Upgrade
|
Other Non Operating Income (Expenses) | -1,179 | 87.62 | 87.12 | 204.9 | 114.29 | 211.23 | Upgrade
|
EBT Excluding Unusual Items | 90,357 | 81,027 | 83,612 | 39,424 | 32,359 | -2,735 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.54 | -0.54 | 1.09 | -2.07 | 0.26 | -3.55 | Upgrade
|
Pretax Income | 90,356 | 81,026 | 83,613 | 39,422 | 32,359 | -2,738 | Upgrade
|
Income Tax Expense | 17,600 | 14,168 | 14,540 | 15,559 | 12,443 | -873.76 | Upgrade
|
Net Income | 72,756 | 66,859 | 69,073 | 23,863 | 19,916 | -1,865 | Upgrade
|
Net Income to Common | 72,756 | 66,859 | 69,073 | 23,863 | 19,916 | -1,865 | Upgrade
|
Net Income Growth | 9.77% | -3.21% | 189.46% | 19.82% | - | - | Upgrade
|
Shares Outstanding (Basic) | 1,754 | 1,754 | 1,754 | 1,754 | 1,754 | 1,754 | Upgrade
|
Shares Outstanding (Diluted) | 1,754 | 1,754 | 1,754 | 1,754 | 1,754 | 1,754 | Upgrade
|
Shares Change (YoY) | 0.01% | - | - | - | - | - | Upgrade
|
EPS (Basic) | 41.47 | 38.11 | 39.37 | 13.60 | 11.35 | -1.06 | Upgrade
|
EPS (Diluted) | 41.47 | 38.11 | 39.37 | 13.60 | 11.35 | -1.06 | Upgrade
|
EPS Growth | 9.76% | -3.21% | 189.46% | 19.82% | - | - | Upgrade
|
Free Cash Flow | 85,734 | 111,388 | 115,882 | 90,353 | 132,776 | 86,140 | Upgrade
|
Free Cash Flow Per Share | 48.87 | 63.49 | 66.05 | 51.50 | 75.68 | 49.10 | Upgrade
|
Dividend Per Share | - | 10.000 | 7.200 | 2.250 | - | - | Upgrade
|
Dividend Growth | - | 38.89% | 220.00% | - | - | - | Upgrade
|
Operating Margin | 19.45% | 17.39% | 15.41% | 6.66% | 7.12% | -1.83% | Upgrade
|
Profit Margin | 15.83% | 14.80% | 14.83% | 4.87% | 4.09% | -0.36% | Upgrade
|
Free Cash Flow Margin | 18.65% | 24.66% | 24.87% | 18.44% | 27.26% | 16.82% | Upgrade
|
EBITDA | 89,440 | 78,654 | 71,900 | 32,763 | 34,820 | -9,201 | Upgrade
|
EBITDA Margin | 19.46% | 17.41% | 15.43% | 6.69% | 7.15% | -1.80% | Upgrade
|
D&A For EBITDA | 70.82 | 89.94 | 96.91 | 137.48 | 149.51 | 182.83 | Upgrade
|
EBIT | 89,369 | 78,564 | 71,803 | 32,625 | 34,671 | -9,383 | Upgrade
|
EBIT Margin | 19.45% | 17.39% | 15.41% | 6.66% | 7.12% | -1.83% | Upgrade
|
Effective Tax Rate | 19.48% | 17.49% | 17.39% | 39.47% | 38.45% | - | Upgrade
|
Source: S&P Capital IQ. Insurance template. Financial Sources.